Patent · US Active

Risk calculation for evaluation of fetal aneuploidy

US12195799B2 · kind B2 · utility

0Cited by
126References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2020
Grant dateJan 14, 2025
Priority date
Expiry dateNov 16, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

The present invention provides processes for determining accurate risk probabilities for fetal aneuploidies. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.